SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001104659-21-140540
Filing Date
2021-11-17
Accepted
2021-11-17 16:00:46
Documents
1

Document Format Files

Seq Description Document Type Size
1 POS AM tm2133223d3_f3.htm POS AM 18576
  Complete submission text file 0001104659-21-140540.txt   19528
Mailing Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9
Business Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9 (416) 595-0627
Trillium Therapeutics Inc. (Filer) CIK: 0001616212 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-237810 | Film No.: 211420551
SIC: 2834 Pharmaceutical Preparations